论文部分内容阅读
目的观察阿托伐他汀抑制肝癌细胞增殖作用。方法选择我院收治90例患者为研究对象，并随机分观察组和对照组各45例。观察组阿托伐他汀治疗，对照组采用常规疗法。对两组患者治疗后效果进行观察。结果观察组总有效率88.89%，明显优于对照组64.44%，差异有统计学意义(<0.05)；观察组在服用阿托伐他汀后，不良反应率为6.66%对照组为20%，两组不良反应率无明显差异(0.05)。结论阿托伐他汀对于抑制肝癌细胞的增殖效果明显，值得在临床推广。“,”Objective To observe the ef ect of atorvastatin on the proliferation of hepatocel ular carcinoma cel s. Methods 90 patients in our hospital were selected as the study object, and were randomly divided into observation group and control group, each of 45 cases. Observation group atorvastatin treatment, the control group using conventional therapy. The ef ect of the treatment for the two groups was observed after treatment.Results In the observation group, the total ef ective rate was 88.89%, significantly higher than that of the control group 64.44%, the dif erence is statistical y significant ( <0.05). In the observation group, atorvastatin, the adverse reaction rate was 6.66%in control group was 20%, the adverse reactions of the two groups rate had no significant dif erence (0.05).Conclusion Atorvastatin for significant inhibitory ef ect on the proliferation of hepatoma cel s, it is worth in clinical promotion.